What Is Anaphylaxis That Caused The First Death In India Linked To Covid-19 Vaccine?

As per reports, anaphylaxis is a very severe allergic reaction whose symptoms begin appearing immediately. If anaphylaxis is not treated immediately, then it could be life-threatening as well.

Aboli Vaze

June 22, 2021

Trending News

2 min

zeenews

The government recently confirmed the first death case in India due to Covid-19 vaccine. As per reports, a 68-year-old man died because of anaphylaxis (a serious and potentially life-threatening allergic reaction) after he was administered the coronavirus vaccine on  March 8. As per a leading daily,  anaphylaxis was also reported in two other people who received the Covid-19 vaccine, however, they recovered after a ‘brief stay in hospital.’

ALSO READ | Under Ayushman Bharat, huge disparities among states where Covid patients availed scheme

What is anaphylaxis?

As per reports, anaphylaxis is a very severe allergic reaction whose symptoms begin appearing immediately. If anaphylaxis is not treated immediately, then it could be life-threatening as well. Some of the symptoms of this allergic reaction include rashes, itching, swelling, cough, difficulty in breathing, drop in pulse rate etc.

ALSO READ | Govt confirms first death due to Covid-19 vaccine

The Adverse Event Following Immunization (AEFI) committee assessed  31 deaths between January to March. While 18 cases were classified as coincidental and not linked to vaccination, 7 cases were indeterminate. There were 2 death cases that could not be classified. A 43-year-old person died after receiving the vaccine on January 18 and a 55-year-old person died after receiving the vaccine on February 5.

Three cases of anaphylaxis, directly linked to the vaccine, have been reported so far. Due to this allergic reaction, only one death has been confirmed so far. As per reports, two people were administered Covishield and one was administered Covaxin.

ALSO READ | Politics over Covaxin: Is Congress responsible for vaccine hesitancy?

NITI Aayog member VK Paul said that there should be ‘no doubt in accepting the vaccine.’ He also mentioned that such serious side effects are very less, almost null. There is a committee set up especially for such cases that will provide treatment immediately.

ALSO READ | Covishield dose gap row: Change due to vaccine shortage or on scientific advice?

For more news stories, visit ZEE5!

Related Topics

Related News

More Loader